Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 35 of 59

Tricuspid Stenosis Table 24. Stages of Severe TS Stage Definition Valve Anatomy Valve Hemodynamics Hemodynamic Consequences Symptoms C, D Severe TS Thickened, distorted, calcified leaflets • T½ ≥190 ms • Valve area ≤1.0 cm 2 RA/IVC enlargement None or variable and dependent on severity of associated valve disease and degree of obstruction e transtricuspid diastolic gradient is highly variable and is affected by heart rate, forward flow, and phases of the respiratory cycle. However, severe TS usually has ∆Pmeans >5-10 mm Hg at heart rate 70. Table 25. Diagnosis and Intervention in Patients With TS Recommendations COR LOE Diagnosis TTE is indicated in patients with TS to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or le-sided valve disease. I C Invasive hemodynamic assessment of severity of TS may be considered in symptomatic patients when clinical and noninvasive data are discordant. IIb C Intervention TV surgery is recommended for patients with severe TS at the time of operation for le-sided valve disease. I C TV surgery is recommended for patients with isolated, symptomatic severe TS. I C Percutaneous balloon tricuspid commissurotomy might be considered in patients with isolated, symptomatic severe TS without accompanying TR. IIb C 34

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease